Core Laboratories N.V. (NYSE: CLB) recently received a number of ratings updates from brokerages and research firms:

  • 8/7/2017 – Core Laboratories N.V. had its price target lowered by analysts at Morgan Stanley from $130.00 to $125.00. They now have an “overweight” rating on the stock.
  • 8/4/2017 – Core Laboratories N.V. was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating.
  • 7/31/2017 – Core Laboratories N.V. was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/26/2017 – Core Laboratories N.V. was given a new $97.00 price target on by analysts at Piper Jaffray Companies. They now have a “hold” rating on the stock.
  • 7/26/2017 – Core Laboratories N.V. had its “neutral” rating reaffirmed by analysts at UBS AG. They now have a $110.00 price target on the stock, down previously from $125.00.
  • 7/26/2017 – Core Laboratories N.V. had its price target lowered by analysts at Citigroup Inc. from $102.00 to $100.00. They now have a “neutral” rating on the stock.
  • 7/17/2017 – Core Laboratories N.V. was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong sell” rating. According to Zacks, “Core Laboratories is anticipated to face near-term headwinds. Weak commodity prices have prompted upstream firms to lower capital spending, which has resulted in lesser work for the likes of Core Laboratories. Since crude prices are expected to remain low well into 2017, cash flows could see a significant decline in the coming months. The paucity of deepwater drilling orders and lower levels of new wells, which will hamper the specialized service provider’s near-term results, are other negatives in the CLB story. Therefore, ahead of its second-quarter results, we see the company as a risky bet that is best avoided at the moment.”
  • 7/5/2017 – Core Laboratories N.V. was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 6/24/2017 – Core Laboratories N.V. was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 6/23/2017 – Core Laboratories N.V. was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Core Laboratories boasts of a unique business model, disciplined financial management and technological expertise. We also like CLB's leadership position in the reservoir optimization niche, along with its global footprint and deep portfolio of proprietary products and services. Furthermore, CLB’s low asset intensive operations and limited capex needs allow it to generate substantial free cash flows. Providing core sample and fluid analysis to oil and natural gas producers in managing their reserves, Core Labs have been able to operate profitably even in this low commodity price environment. However, we see limited upside potential for shares due to the paucity of deepwater drilling orders and lower levels of new wells, which will hamper the specialized service provider’s near-term results.”
  • 6/21/2017 – Core Laboratories N.V. had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $130.00 price target on the stock, down previously from $150.00.
  • 6/17/2017 – Core Laboratories N.V. was given a new $145.00 price target on by analysts at Royal Bank Of Canada. They now have a “buy” rating on the stock.
  • 6/13/2017 – Core Laboratories N.V. was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 6/12/2017 – Core Laboratories N.V. was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $116.00 price target on the stock. According to Zacks, “Considering, Core Laboratories' unique business model, disciplined financial management and technological expertise, we are taking a bullish stance on the company. As it is, we like CLB's leadership position in the reservoir optimization niche, along with its global footprint and deep portfolio of proprietary products and services. Furthermore, CLB’s low asset intensive operations and limited capex needs allow it to generate substantial free cash flows. Providing core sample and fluid analysis to oil and natural gas producers in managing their reserves, Core Labs have been able to operate profitably even in this low commodity price environment. In fact, the existing tight oil price scenario has made CLB's services even more important for energy companies that look to utilize every dollar that they spend. Consequently, we think CLB offers substantial upside potential from the current price levels.”

Core Laboratories N.V. (CLB) traded down 1.94% on Monday, hitting $99.98. 407,242 shares of the stock traded hands. The stock has a market cap of $4.41 billion, a P/E ratio of 61.34 and a beta of 1.60. The stock has a 50-day moving average price of $102.90 and a 200 day moving average price of $109.93. Core Laboratories N.V. has a 12-month low of $96.30 and a 12-month high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last issued its quarterly earnings data on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.01. The business had revenue of $163.90 million during the quarter, compared to analyst estimates of $168.23 million. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter last year, the business earned $0.35 EPS. On average, equities analysts expect that Core Laboratories N.V. will post $2.10 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 14th. Investors of record on Monday, July 17th will be issued a $0.55 dividend. The ex-dividend date of this dividend is Thursday, July 13th. This represents a $2.20 dividend on an annualized basis and a yield of 2.20%. Core Laboratories N.V.’s dividend payout ratio (DPR) is presently 134.15%.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Receive News & Ratings for Core Laboratories NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories NV and related companies with MarketBeat.com's FREE daily email newsletter.